Anti-integrins as a potential therapeutic target in angiogenesis
- 1 September 1999
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 9 (9) , 1237-1248
- https://doi.org/10.1517/13543776.9.9.1237
Abstract
Several physiological processes including cell activation, migration, proliferation and differentiation require direct contact between cells or extracellular matrix (ECM) proteins. Cell-cell and cell-matrix interactions are mediated through several different families of cell adhesion molecules (CAMs), including the selectins, the integrins, the cadherins and the immunoglobulins. Newly discovered CAMs, along with the discovery of new roles of integrins, selectins and immunoglobulins in certain disease states, provide a great opportunity to develop therapeutic, and perhaps diagnostic, modalities.CAMs play a very significant and critical role in both normal and pathophysiological disease states. For this key reason, the selection of specific and relevant CAMs to target certain disease conditions, without interfering with other normal cellular functions is a very important prerequisite for the ultimate success in developing truly active and safe therapeutic strategies. Recent breakthroughs with animal models,...Keywords
This publication has 65 references indexed in Scilit:
- Solid-phase synthesis of a selective αvβ3 integrin antagonist libraryBioorganic & Medicinal Chemistry Letters, 1997
- Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.The Journal of cell biology, 1996
- Confocal Microscopic Analysis of Integrin Expression on the Microvasculature and its Sprouts in the Neonatal ForeskinJournal of Investigative Dermatology, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumoursThe Journal of Pathology, 1993
- Conformation/activity studies of rationally designed potent anti‐adhesive RGD peptidesEuropean Journal of Biochemistry, 1992
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- ArgGlyAsp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts*1Experimental Cell Research, 1991
- Arg-Gly-Asp: A versatile cell recognition signalCell, 1986